|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Cash and investment held in Trust Account | |||||||||
| Cash held in Escrow Account | |||||||||
| Total Assets | |||||||||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Due to related party | |||||||||
| Promissory note - related party | |||||||||
| Due to related parties | |||||||||
| Due to related parties | |||||||||
| Related Party | |||||||||
| Total due to related parties | |||||||||
| Promissory notes | |||||||||
| Related Party | |||||||||
| Total promissory notes | |||||||||
| Promissory notes - related party | |||||||||
| Total Current Liabilities | |||||||||
| Deferred underwriting discounts and commissions | |||||||||
| Deferred underwriting discounts and commissions | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 3,837,766 shares and 6,587,231 shares at redemption value of $11.21 and $10.65 per share as of March 31, 2024 and June 30, 2023, respectively | |||||||||
| Class A Ordinary Shares | |||||||||
| Total class A ordinary shares subject to possible redemption, 3,837,766 shares and 6,587,231 shares at redemption value of $11.21 and $10.65 per share as of March 31, 2024 and June 30, 2023, respectively | |||||||||
| Shareholders’ Deficit: | |||||||||
| Ordinary shares | |||||||||
| Class A Ordinary Shares | |||||||||
| Class B Ordinary Shares | |||||||||
| Total ordinary shares | |||||||||
| Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized, 2,300,000 shares issued and outstanding | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders’ Deficit | |||||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
